Remediation Solutions

ELIQUENT brings together former FDA, EMA, and PMDA reviewers who understand how agencies think, from early strategy through market approval and lifecycle management. Across 52 countries, ELIQUENT works at every point on the pathway: pipeline and designation strategy, CMC, clinical programs, submissions, la...

ELIQUENT's Quality & Compliance practice is led by former FDA, EMA, and PMDA regulators and reaches across the full product lifecycle: designing and optimising quality systems, hardening laboratory controls and data integrity, strengthening supply chains, and guiding companies through regulatory meetin...

ELIQUENT's pharmacovigilance team includes industry-recognised safety leaders who own the full post-market safety picture, from signal detection and adverse event reporting to inspection readiness and operating model design across global markets. ELIQUENT keeps your product safe and trusted long after appr...

When you're ready to scale from clinical to commercial, ELIQUENT's GxP practice pairs experienced engineers with former FDA, EMA, MHRA, and PMDA regulators, turning intricate engineering requirements into validated facilities, qualified processes, and inspection-ready systems. From lab to launch and everyt...

Explore ELIQUENT’s integrated regulatory, quality and safety expertise, supporting life sciences organisations across the product lifecycle and around the world.

Discover how ELIQUENT brings together global regulatory, quality and safety expertise to help life sciences organisations navigate complexity and keep critical work moving.

Visit our Website to talk to an ELIQUENT team member.

AI is changing where value is created in life sciences. ELIQUENT’s executive briefing discusses where competitive advantage in AI regulatory workflows truly lives.

Download now.

This ELIQUENT webinar covers data integrity history, regulatory expectations, CMC implications and the changing IT landscape and is highly relevant to pharma manufacturing and quality audiences.

Watch now.

Eight-episode series on ELIQUENT's YouTube channel, covering aspects of EU Medical Device Regulation (MDR) and the considerations that matter for ongoing compliance.

Watch now.

As regulatory scrutiny intensifies and safety data grows increasingly complex, biopharmaceutical organizations must move beyond fragmented, reactive approaches to safety communication. 

This white paper explores how companies can establish robust, harmonized safety communication frameworks that improve compliance, strengthen stakeholder trust, and ultimately support patient safety.
Discover practical strategies for building clear, consistent and compliant safety communications across global pharmacovigilance organisations. 
 
Download now.